Latigo Biotherapeutics, Inc. (LTGO)
Latigo Biotherapeutics Market Cap : 1.398B for Sept. 21, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 1.495B |
| September 17, 2026 | 1.587B |
| September 16, 2026 | 1.529B |
| September 15, 2026 | 1.526B |
| September 14, 2026 | 1.501B |
| September 11, 2026 | 1.469B |
| September 10, 2026 | 1.428B |
| September 09, 2026 | 1.512B |
| September 08, 2026 | 1.573B |
| September 04, 2026 | 1.528B |
| September 03, 2026 | 1.490B |
| September 02, 2026 | 1.443B |
| September 01, 2026 | 1.408B |
| August 31, 2026 | 1.393B |
| August 28, 2026 | 1.532B |
| August 27, 2026 | 1.581B |
| Date | Value |
|---|---|
| August 26, 2026 | 1.526B |
| August 25, 2026 | 1.427B |
| August 24, 2026 | 1.391B |
| August 21, 2026 | 1.415B |
| August 20, 2026 | 1.353B |
| August 19, 2026 | 1.324B |
| August 18, 2026 | 1.265B |
| August 17, 2026 | 1.220B |
| August 14, 2026 | 1.233B |
| August 13, 2026 | 1.269B |
| August 12, 2026 | 1.225B |
| August 11, 2026 | 1.171B |
| August 10, 2026 | 1.174B |
| August 07, 2026 | 1.154B |
| August 06, 2026 | 1.138B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.811B |
| Corcept Therapeutics, Inc. | 12.27B |
| Veru, Inc. | 41.77M |
| Johnson & Johnson | 649.09B |
| Eli Lilly & Co. | 1.097T |
Market Cap Related Metrics
| Price | 21.08 |
| Earnings Yield | -7.08% |